Literature DB >> 30965107

Effects of pycnogenol on ischemia/reperfusion-induced inflammatory and oxidative brain injury in rats.

Baris Ozoner1, Sahin Yuceli2, Seckin Aydin3, Gulce Naz Yazici4, Mukadder Sunar5, Yusuf Kemal Arslan6, Taha Abdulkadir Coban7, Halis Suleyman8.   

Abstract

BACKGROUND: Ischemia/reperfusion (I/R) injury results from the onset of re-circulation following a perfusion deterioration period in the tissues, resulting in more damage than that caused by perfusion deterioration. This study aimed to determine the effects of pycnogenol on I/R injury in rat brain tissues.
METHODS: Eighteen albino Wistar rats were divided into three groups: I/R injury (IR, n = 6) group; I/R injury + pycnogenol (IR + P, n = 6) group; and sham group (SG, n = 6). After 30 min of transient ischemia, 24 h of reperfusion was achieved in the IR and IR + P groups. Surgical dissection, except for transient ischemia, was performed in SG. Next, histopathological and biochemical investigations were performed on brain tissues. Malondialdehyde (MDA), reduced glutathione (GSH), and glutathione peroxidase (GPO) were analyzed as oxidative stress markers; IL-1β and TNF-α were analyzed as inflammatory stress markers in biochemical tests.
RESULTS: Histopathological examination revealed normal morphology in SG and diffuse cortex damage with edema, vasopathology, and inflammatory cell infiltration in the IR group. The IR + P group showed less cortex damage, edema, and vasopathology than the IR group. The MDA, IL-1β, and TNF-α levels were significantly higher in the IR group than those in the SG group. The values of same markers for the IR + P group were significantly lower than the IR group. The GSH and GPO levels were significantly decreased with IR damage, but PYC treatment showed significant improvement in the levels.
CONCLUSION: This study showed that the administration of pycnogenol ameliorated brain damage after I/R injury by reducing oxidative and inflammatory damage in the rat brain.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-inflammatory; Antioxidant; Brain injury; Ischemia/reperfusion; Pycnogenol

Year:  2019        PMID: 30965107     DOI: 10.1016/j.neulet.2019.04.010

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  6 in total

1.  Improvement of cerebral ischemia-reperfusion injury by L-3-n-butylphthalide through promoting angiogenesis.

Authors:  Ying Huang; Lishou Pan; Ting Wu
Journal:  Exp Brain Res       Date:  2020-11-12       Impact factor: 1.972

2.  Protective Effect of Pycnogenol against Methotrexate-Induced Hepatic, Renal, and Cardiac Toxicity: An In Vivo Study.

Authors:  Faten Al-Abkal; Basel A Abdel-Wahab; Hanaa F Abd El-Kareem; Yasser M Moustafa; Dina M Khodeer
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-27

3.  Classification of Contrasting Discrete Emotional States Indicated by EEG Based Graph Theoretical Network Measures.

Authors:  Berke Kılıç; Serap Aydın
Journal:  Neuroinformatics       Date:  2022-03-14

4.  Activation of PPAR-β/δ Attenuates Brain Injury by Suppressing Inflammation and Apoptosis in a Collagenase-Induced Intracerebral Hemorrhage Mouse Model.

Authors:  Xiangming Tang; Kunning Yan; Yingge Wang; Yaping Wang; Hongmei Chen; Jiang Xu; Yaoyao Lu; Xiaohong Wang; Jingyan Liang; Xinjiang Zhang
Journal:  Neurochem Res       Date:  2020-01-14       Impact factor: 4.414

5.  Pycnogenol® Supplementation Attenuates Memory Deficits and Protects Hippocampal CA1 Pyramidal Neurons via Antioxidative Role in a Gerbil Model of Transient Forebrain Ischemia.

Authors:  Bora Kim; Tae-Kyeong Lee; Cheol Woo Park; Dae Won Kim; Ji Hyeon Ahn; Hyejin Sim; Jae-Chul Lee; Go Eun Yang; Jong Dai Kim; Myoung Cheol Shin; Jun Hwi Cho; Sungwoo Ryoo; Young-Myeong Kim; Moo-Ho Won; Joon Ha Park
Journal:  Nutrients       Date:  2020-08-17       Impact factor: 5.717

Review 6.  Long Non-coding RNAs as Promising Therapeutic Approach in Ischemic Stroke: a Comprehensive Review.

Authors:  Marta Wolska; Joanna Jarosz-Popek; Eva Junger; Zofia Wicik; Tahmina Porshoor; Lucia Sharif; Pamela Czajka; Marek Postula; Dagmara Mirowska-Guzel; Anna Czlonkowska; Ceren Eyileten
Journal:  Mol Neurobiol       Date:  2020-11-24       Impact factor: 5.590

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.